Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 6,842 | 3,311 | 2,709 | 2,481 | 3,325 |
| Operating Income | -6,842 | -3,311 | -2,709 | -2,481 | -3,325 |
| Other Income | 28 | 41 | 69 | 40 | 33 |
| Pre-tax Income | -6,814 | -3,270 | -2,640 | -2,441 | -3,292 |
| Net Income Continuous | -6,814 | -3,270 | -2,640 | -2,441 | -3,292 |
| Net Income | $-6,814 | $-3,270 | $-2,640 | $-2,441 | $-3,292 |
| EPS Basic Total Ops | -103.55 | -49.52 | -49.52 | -49.52 | -85.54 |
| EPS Basic Continuous Ops | -105.63 | -48.77 | -49.40 | -51.57 | -85.19 |
| EPS Diluted Total Ops | -103.55 | -49.52 | -49.52 | -49.52 | -85.54 |
| EPS Diluted Continuous Ops | -105.63 | -48.77 | -49.40 | -51.57 | -85.19 |
| EBITDA(a) | $-6,826 | $-3,293 | $-2,689 | $-2,458 | $-3,302 |